ArticleBMJ open2018

Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial.

Alexander Sidelmann Christensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.